SEC Form 4 reporting owner

Giordano Christopher Thomas

Giordano Christopher Thomas has filed 5 Form 4 transactions reported between January 9, 2026 and September 15, 2026, as CEO of TENAX THERAPEUTICS, INC..

Name as filed: Giordano Christopher Thomas

Open-market buys, 24 mo
$20K
2 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Sep 15, 2026
transaction date

Roles and reported holdings

  • TENXTENAX THERAPEUTICS, INC.
    Jan 9, 2026 – Sep 15, 2026

    CEO

    Held directly22,174 sh as of Sep 15, 2026 · Form 4

    24 months: $20K bought

Transaction history

All 5 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 15, 2026TENXCEOOpen-market purchaseCode P · direct4,850$9K@ $1.82Form 4
Sep 11, 2026TENXCEOOpen-market purchaseCode P · direct6,000$11K@ $1.88Form 4
Jul 13, 2026TENXCEOOption exerciseCode M · direct8,500$50K@ $5.94Form 4
Jul 13, 2026TENXCEOOption exerciseCode M · direct219$777@ $3.55Form 4
Jan 9, 2026TENXCEOGrant or awardCode A · direct450,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.